Citius Oncology, Inc. CTOR Effective Income Tax Rate Reconciliation Permanent Differences

Effective Income Tax Rate Reconciliation Permanent Differences at other companies

RE/MAX HoldingsRMAX

23.3%+20.7pp

ZumiezZUMZ

6%+5.7pp

Community Health SystemsCYH

$750K-57.1%

Spectral AI, Inc.MDAI

-7.3%-0.7pp

Community Health SystemsCYH

0.4%+0.2pp

Envoy MedicalCOCH

-0.6%—

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Operating cash flow-$3.8M-179%

Market cap$60.45M-74.7%

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept ctor:EffectiveIncomeTaxRateReconciliationPermanentDifferences.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Citius Oncology, Inc.'s effective income tax rate reconciliation permanent differences?: Citius Oncology, Inc. (CTOR) reported effective income tax rate reconciliation permanent differences of 6.3% in Q3 2025.
What does effective income tax rate reconciliation permanent differences mean?: Measures the impact of items that are recognized for financial reporting but will never be recognized for tax purposes. This reconciliation item explains deviations from the statutory tax rate due to permanent book-tax differences.